Dr. Fernanda Musa, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $49,602 | 20 | 59.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,840 | 4 | 17.9% |
| Travel and Lodging | $13,946 | 21 | 16.8% |
| Education | $2,587 | 4 | 3.1% |
| Food and Beverage | $1,920 | 32 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $32,406 | 16 | $0 (2024) |
| Merck Sharp & Dohme LLC | $17,470 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $11,312 | 9 | $0 (2023) |
| Seagen Inc. | $6,568 | 2 | $0 (2021) |
| Intuitive Surgical, Inc. | $4,265 | 22 | $0 (2022) |
| Genmab U.S., Inc. | $2,651 | 3 | $0 (2024) |
| BioNTech SE | $2,200 | 1 | $0 (2023) |
| CooperSurgical, Inc. | $2,025 | 2 | $0 (2022) |
| Aadi Bioscience, Inc. | $1,914 | 3 | $0 (2024) |
| Clovis Oncology, Inc. | $1,785 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41,638 | 26 | GlaxoSmithKline, LLC. ($19,603) |
| 2023 | $11,595 | 6 | GlaxoSmithKline, LLC. ($6,600) |
| 2022 | $6,044 | 10 | GlaxoSmithKline, LLC. ($2,830) |
| 2021 | $16,901 | 10 | AstraZeneca Pharmaceuticals LP ($8,220) |
| 2020 | $3,000 | 2 | Clovis Oncology, Inc. ($1,700) |
| 2019 | $386.20 | 7 | Intuitive Surgical, Inc. ($209.61) |
| 2018 | $3,330 | 20 | Intuitive Surgical, Inc. ($2,930) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Consulting Fee | In-kind items and services | $2,625.00 | General |
| Category: Oncology | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $889.45 | General |
| 11/21/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $603.56 | General |
| 11/21/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $388.64 | General |
| 11/12/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Travel and Lodging | In-kind items and services | $621.60 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Travel and Lodging | In-kind items and services | $437.83 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Travel and Lodging | In-kind items and services | $128.65 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Oncology | ||||||
| 10/19/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Travel and Lodging | In-kind items and services | $752.70 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Travel and Lodging | In-kind items and services | $345.61 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $123.67 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $9,169.59 | General |
| 08/12/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $5,600.00 | General |
| 07/26/2024 | Aadi Bioscience, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,712.50 | General |
| 07/26/2024 | Aadi Bioscience, Inc. | — | Food and Beverage | In-kind items and services | $112.50 | General |
| 04/17/2024 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,100.00 | General |
| 03/16/2024 | Aadi Bioscience, Inc. | Fyarro (Drug) | Food and Beverage | In-kind items and services | $89.00 | General |
| Category: Cancer | ||||||
| 02/22/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: ONCOLOGY | ||||||
| 01/24/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $123.60 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 136 | 183 | $100,400 | $29,960 |
| 2022 | 6 | 138 | 188 | $110,344 | $33,699 |
| 2021 | 6 | 141 | 169 | $111,445 | $34,921 |
| 2020 | 5 | 106 | 146 | $78,186 | $23,474 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 14 | 14 | $37,739 | $10,532 | 27.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $20,190 | $6,028 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 44 | $13,952 | $4,865 | 34.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 32 | $14,401 | $4,615 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 60 | $14,118 | $3,920 | 27.8% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 18 | 18 | $46,472 | $13,312 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 53 | $16,710 | $5,750 | 34.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $18,965 | $5,459 | 28.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 25 | $10,805 | $3,806 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 48 | $10,624 | $3,407 | 32.1% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2022 | 12 | 12 | $6,768 | $1,964 | 29.0% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 22 | 22 | $53,812 | $16,124 | 30.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 38 | 38 | $21,972 | $7,245 | 33.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 38 | $11,970 | $3,952 | 33.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 21 | $9,084 | $3,241 | 35.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 39 | $8,603 | $2,659 | 30.9% |
| 38900 | Lymph node imaging during surgery | Facility | 2021 | 11 | 11 | $6,005 | $1,700 | 28.3% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2020 | 13 | 13 | $33,018 | $9,981 | 30.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 36 | 36 | $19,426 | $6,152 | 31.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 39 | $11,273 | $3,192 | 28.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 42 | $8,153 | $2,407 | 29.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 16 | $6,316 | $1,742 | 27.6% |
About Dr. Fernanda Musa, M.D
Dr. Fernanda Musa, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1700044054.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fernanda Musa, M.D has received a total of $82,894 in payments from pharmaceutical and medical device companies, with $41,638 received in 2024. These payments were reported across 81 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($49,602).
As a Medicare-enrolled provider, Musa has provided services to 521 Medicare beneficiaries, totaling 686 services with total Medicare billing of $122,054. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Obstetrics & Gynecology, Gynecologic Oncology
- Location Seattle, WA
- Active Since 05/22/2008
- Last Updated 12/06/2025
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1700044054
Products in Payments
- ZEJULA (Drug) $14,807
- LYNPARZA (Biological) $11,370
- LYNPARZA (Drug) $8,539
- Da Vinci Surgical System (Device) $3,265
- Epkinly (Drug) $2,651
- Advincula Delineator Uterine Manipulator (Device) $2,025
- Rubraca (Drug) $1,785
- DAVINCI XI (Device) $1,000
- Fyarro (Drug) $89.00
- PROCLAIM (Device) $29.88
- CALDOLOR (Drug) $28.25
- FOUNDATIONONE (Device) $23.68
- Proclaim IPG (Device) $12.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Seattle
Dr. Rod Oskouian, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $2.4M
Dr. Gordana Juric-Sekhar, Md Phd, MD PHD
Student in an Organized Health Care Education/Training Program — Payments: $873,399
Ashley Fuller, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $55,265
George Schade, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $51,659
Mr. Jia-Wei Ko, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $34,850
Mr. Amir Abdul-Jabbar, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $33,317